Your browser doesn't support javascript.
loading
Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery.
Knowles, Stephen P; Printz, Marie A; Kang, David W; LaBarre, Michael J; Tannenbaum, Renee P.
Affiliation
  • Knowles SP; Halozyme Therapeutics, Inc, San Diego, CA, USA.
  • Printz MA; Halozyme Therapeutics, Inc, San Diego, CA, USA.
  • Kang DW; Halozyme Therapeutics, Inc, San Diego, CA, USA.
  • LaBarre MJ; Halozyme Therapeutics, Inc, San Diego, CA, USA.
  • Tannenbaum RP; Halozyme Therapeutics, Inc, San Diego, CA, USA.
Expert Opin Drug Deliv ; 18(11): 1673-1685, 2021 11.
Article in En | MEDLINE | ID: mdl-34585991
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Hyaluronoglucosaminidase Limits: Aged / Child / Female / Humans / Pregnancy Language: En Journal: Expert Opin Drug Deliv Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Hyaluronoglucosaminidase Limits: Aged / Child / Female / Humans / Pregnancy Language: En Journal: Expert Opin Drug Deliv Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Country of publication: